Tag: medicines

Supplementary protection certificates in Europe: towards a unified system and the extension of biotech protection
04/21/2026
The European regime on supplementary protection certificates could undergo a huge transformation. The EU has proposed measures such as introducing a centralized examination procedure at the European Union Intellectual Property Office (EUIPO), creating a unitary supplementary protection certificate or extending protection by a further 12 months for some medicines developed using biotech processes and for […]
